These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 22504459

  • 1. Glycosaminoglycan backbone is not required for the modulation of hemostasis: effect of different heparin derivatives and non-glycosaminoglycan analogs.
    Bouças RI, Jarrouge-Bouças TR, Lima MA, Trindade ES, Moraes FA, Cavalheiro RP, Tersariol IL, Hoppenstead D, Fareed J, Nader HB.
    Matrix Biol; 2012 Jun; 31(5):308-16. PubMed ID: 22504459
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Internalization and degradation of heparin is not required for stimulus of heparan sulfate proteoglycan synthesis.
    Trindade ES, Bouças RI, Rocha HA, Dominato JA, Paredes-Gamero EJ, Franco CR, Oliver C, Jamur MC, Dietrich CP, Nader HB.
    J Cell Physiol; 2008 Nov; 217(2):360-6. PubMed ID: 18546203
    [Abstract] [Full Text] [Related]

  • 4. Effect of new synthetic heparin mimetics on whole blood thrombin generation in vivo and in vitro in rats.
    Hérault JP, Bernat A, Gaich C, Herbert M.
    Thromb Haemost; 2002 Feb; 87(2):238-44. PubMed ID: 11858483
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Synthesis of thrombin-inhibiting heparin mimetics without side effects.
    Petitou M, Hérault JP, Bernat A, Driguez PA, Duchaussoy P, Lormeau JC, Herbert JM.
    Nature; 1999 Apr 01; 398(6726):417-22. PubMed ID: 10201371
    [Abstract] [Full Text] [Related]

  • 10. Pharmacokinetics of new synthetic heparin mimetics.
    Hérault JP, Bernat A, Roye F, Michaux C, Schaeffer P, Bono F, Petitou M, Herbert JM.
    Thromb Haemost; 2002 Jun 01; 87(6):985-9. PubMed ID: 12083506
    [Abstract] [Full Text] [Related]

  • 11. Pharmacological profile of the chemically synthesized antithrombin III binding fragment of heparin (pentasaccharide) in rats.
    Hobbelen PM, van Dinther TG, Vogel GM, van Boeckel CA, Moelker HC, Meuleman DG.
    Thromb Haemost; 1990 Apr 12; 63(2):265-70. PubMed ID: 2363127
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Heparin induces synthesis and secretion of tissue factor pathway inhibitor from endothelial cells in vitro.
    Hansen JB, Svensson B, Olsen R, Ezban M, Osterud B, Paulssen RH.
    Thromb Haemost; 2000 Jun 12; 83(6):937-43. PubMed ID: 10896252
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Absorption and antithrombotic activity of unfractioned heparin after intraduodenal administration in rats.
    Costantini V, Deveglia R, Stabile A, Nenci GG.
    Blood Coagul Fibrinolysis; 2000 Jan 12; 11(1):7-13. PubMed ID: 10691095
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Dual effects of sulfated D-galactans from the red algae Botryocladia occidentalis preventing thrombosis and inducing platelet aggregation.
    Farias WR, Nazareth RA, Mourão PA.
    Thromb Haemost; 2001 Dec 12; 86(6):1540-6. PubMed ID: 11776325
    [Abstract] [Full Text] [Related]

  • 20. Pharmacological actions of sulodexide.
    Ofosu FA.
    Semin Thromb Hemost; 1998 Dec 12; 24(2):127-38. PubMed ID: 9579633
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.